<DOC>
	<DOCNO>NCT02953132</DOCNO>
	<brief_summary>The purpose study investigate safety tolerability ascend single multiple oral dos MT-4129 healthy subject .</brief_summary>
	<brief_title>A Clinical Study See How Study Drug MT-4129 Taken Body Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy free clinically significant illness disease Male female subject age 18 55 year elderly male subject age ≥65 A body weight ≥60 kg male ≥50 kg female , body mass index range 18 30 kg/m2 Participated three clinical study involve administration IMP previous year , study within 12 week Clinically significant endocrine , thyroid , hepatic , respiratory , gastro intestinal , neurological , renal , cardiovascular disease , history significant psychiatric/psychotic illness disorder Clinically relevant abnormal medical history , physical finding laboratory value</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>